Some considerations on pathogenesis and treatment of acrodematitis continua supprativa (Hallopeau).
D000169:Acrodermatitis; D006801:Humans; D007610:Kallikreins; D014043:Tolazoline
D014043:Tolazoline; D007610:Kallikreins
ACRODERMATITIS; KALLIKREIN; TOLAZOLINE